Rejuvenation Technologies Inc. YC 지원서

Summer 2018Active

Rejuvenation Technologies Inc.은(는) Summer 2018 배치에서 Healthcare 회사로 Y Combinator를 거쳤습니다. 아래에는 회사의 사업 내용, 창립자, 그리고 실제 YC 양식에 맞춰 재구성한 YC 지원서가 있습니다.

YC 배치: Summer 2018
산업: HealthcareTherapeutics
팀 규모: 2
상태: Active
출시됨: 2018

창업자

Glenn MarkovFounder
John RamunasFounder

Rejuvenation Technologies Inc.의 사업 내용

Stanford-patented essential drug platform unlocks the healthspan, which is limited by short telomeres. Extends mouse lifespan by equivalent of 10 years in humans. Reverses 5-10 years of telomere shortening with one dose in one day. Preclinical efficacy in 4 organ systems including immune system. Entering clinical stage. CEO is Subject #1 in longevity trial. 50+ granted patents, 7 patent families. FDA INTERACT cleared. Raising $10M seed extension ($2M+ wired) to fund 3 investigator-initiated trials. Readouts in Q3 2027. $6.8B in comparable mRNA-LNP M&A in last 12 months.

Rejuvenation Technologies Inc.의 YC 지원서, 재구성됨

Y Combinator 지원

Rejuvenation Technologies Inc., Summer 2018 기수. 공개 데이터를 기반으로 작성된 실제 지원 질문.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Rejuvenation Technologies Inc.

Describe what your company does in 50 characters or less.

mRNA therapeutics to extend healthspan

What is your company going to make? Please describe your product and what it does or will do.

We develop an mRNA drug platform that extends healthspan by reversing telomere shortening. Our therapy extends mouse lifespan by the human equivalent of 10 years with a single dose, showing efficacy in multiple organ systems, including the immune system. We are entering clinical trials to validate this approach in humans, addressing the root cause of aging linked to short telomeres.

Where do you live now, and where would the company be based after YC?

We live and work in San Francisco, CA, and plan to base the company here after YC as well.

Explain your decision regarding location.

San Francisco offers the right ecosystem of biotech expertise, funding, and clinical trial access. Being where the science and capital meet is necessary for our clinical-stage gene therapy startup.

전체 지원서에서 21개의 추가 답변

Founders, Progress, Idea, Equity, Curious, Batch Preference는 전체 버전에 있습니다. 무료 계정을 만들어 YC Insights에서 모든 YC 배치 옆에 열어보세요.

전체 지원 보기

자주 묻는 질문

Rejuvenation Technologies Inc.의 실제 YC 지원서인가요?

아닙니다. Y Combinator는 제출된 지원서를 비공개로 유지합니다. 이것은 재구성된 것입니다. 실제 YC 양식 질문에 Rejuvenation Technologies Inc.의 공개 데이터(출시 노트, 창업자 배경, 제품 설명)를 기반으로 답변했습니다. Rejuvenation Technologies Inc.과 같은 회사가 YC에 어떻게 자신을 소개하는지 보여주며, 그들이 제출한 텍스트는 아닙니다.